Abstract:Here, we report that senescent cells upregulate the two major types of autophagy, chaperone‐mediated autophagy, and macroautophagy. We analyze the proteome of lysosomes engaged in each pathway, identifying novel markers of senescent cells. We also report that some senescent cells can perform direct lysosomal exocytosis by which lysosomal components contribute to the SASP and to serum markers of aging. Senescent cells accumulate in tissues over time, favoring the onset and progression of multiple age‐related diseases. Senescent cells present a remarkable increase in lysosomal mass and elevated autophagic activity. Here, we report that two main autophagic pathways macroautophagy (MA) and chaperone‐mediated autophagy (CMA) are constitutively upregulated in senescent cells. Proteomic analyses of the subpopulations of lysosomes preferentially engaged in each of these types of autophagy revealed profound quantitative and qualitative changes in senescent cells, affecting both lysosomal resident proteins and cargo proteins delivered to lysosomes for degradation. These studies have led us to identify resident lysosomal proteins that are highly augmented in senescent cells and can be used as novel markers of senescence, such as arylsulfatase ARSA. The abundant secretome of senescent cells, known as SASP, is considered their main pathological mediator; however, little is known about the mechanisms of SASP secretion. Some secretory cells, including melanocytes, use the small GTPase RAB27A to perform lysosomal secretion. We found that this process is exacerbated in the case of senescent melanoma cells, as revealed by the exposure of lysosomal membrane integral proteins LAMP1 and LAMP2 in their plasma membrane. Interestingly, a subset of SASP components, including cytokines CCL2, CCL3, CXCL12, cathepsin CTSD, or the protease inhibitor SERPINE1, are secreted in a RAB27A‐dependent manner in senescent melanoma cells. Finally, proteins previously identified as plasma biomarkers of aging are highly enriched in the lysosomes of senescent cells, including CTSD. We conclude that the lysosomal proteome of senescent cells is profoundly reconfigured, and that some senescent cells can be highly active in lysosomal exocytosis.

A Proteomic Atlas of Senescence-Associated Secretomes for Aging Biomarker Development

The senescence-associated secretome as an indicator of age and medical risk

A plasma proteomic signature links secretome of senescent monocytes to aging- and obesity-related clinical outcomes in humans

The power of proteomics to monitor senescence-associated secretory phenotypes and beyond: toward clinical applications

An unbiased proteomics approach to identify the senescence-associated secretory phenotype of human bone marrow-derived mesenchymal stem cells

Detection of the senescence-associated secretory phenotype (SASP)

Prognostic Significance and Biologic Associations of Senescence-Associated Secretory Phenotype Biomarkers in Heart Failure

The senescence-associated secretory phenotype and its physiological and pathological implications

Exosomes Released from Senescent Cells and Circulatory Exosomes Isolated from Human Plasma Reveal Aging-associated Proteomic and Lipid Signatures

Meta-analysis of senescent cell secretomes to identify common and specific features of the different senescent phenotypes: a tool for developing new senotherapeutics

Biomarkers of cellular senescence and risk of death in humans

Proteomics in aging research: A roadmap to clinical, translational research

Characterization of human senescent cell biomarkers for clinical trials

The lysosomal proteome of senescent cells contributes to the senescence secretome

A molecular index for biological age identified from the metabolome and senescence‐associated secretome in humans

The Senescence-Associated Secretory Phenotype (SASP) in the Challenging Future of Cancer Therapy and Age-Related Diseases

Analysis of the senescence-associated cell surfaceome reveals potential senotherapeutic targets

Unique Human and Mouse β-Cell Senescence-Associated Secretory Phenotype (SASP) Reveal Conserved Signaling Pathways and Heterogeneous Factors

Markers of aging: Unsupervised integrated analyses of the human plasma proteome

Senescence and the SASP: many therapeutic avenues

Systematic transcriptomic analysis and temporal modelling of the senescent human fibroblast